Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
22.52B
Market cap22.52B
Price-Earnings ratio
23.13
Price-Earnings ratio23.13
Dividend yield
1.58%
Dividend yield1.58%
Average volume
1.31M
Average volume1.31M
High today
$204.42
High today$204.42
Low today
$200.94
Low today$200.94
Open price
$204.26
Open price$204.26
Volume
627.57K
Volume627.57K
52 Week high
$213.20
52 Week high$213.20
52 Week low
$157.20
52 Week low$157.20

Stock Snapshot

With a market cap of 22.52B, Quest Diagnostics(DGX) trades at $202.41. The stock has a price-to-earnings ratio of 23.13 and currently yields dividends of 1.6%.

During the trading session on 2026-02-22, Quest Diagnostics(DGX) shares reached a daily high of $204.42 and a low of $200.94. At a current price of $202.41, the stock is +0.7% higher than the low and still -1.0% under the high.

Trading activity shows a volume of 627.57K, compared to an average daily volume of 1.31M.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $213.20 and a low of $157.20.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $213.20 and a low of $157.20.

DGX News

Simply Wall St 5d
Evaluating Quest Diagnostics After Dividend Hike Strong Earnings Guidance And Expanded Buyback

Quest Diagnostics (DGX) is back in focus after a busy February 10 update, combining higher quarterly and full year 2025 earnings, fresh 2026 guidance, a 7.5% di...

Evaluating Quest Diagnostics After Dividend Hike Strong Earnings Guidance And Expanded Buyback
Simply Wall St 7d
Quest Diagnostics Is Up 8.5% After Strong 2026 Guidance And New Myeloma Test Launch - Has The Bull Case Changed?

In February 2026, Quest Diagnostics reported Q4 and full-year 2025 results with higher sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 bi...

Quest Diagnostics Is Up 8.5% After Strong 2026 Guidance And New Myeloma Test Launch - Has The Bull Case Changed?

Analyst ratings

52%

of 21 ratings
Buy
42.9%
Hold
52.4%
Sell
4.8%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.